- Home
- FGNX vs NAOV Comparison
FGNX vs NAOV Comparison
Compare FGNX & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGNX
- NAOV
- Stock Information
- Founded
- FGNX 1932
- NAOV 2003
- Country
- FGNX United States
- NAOV United States
- Employees
- FGNX N/A
- NAOV N/A
- Industry
- FGNX Property-Casualty Insurers
- NAOV Industrial Specialties
- Sector
- FGNX Finance
- NAOV Health Care
- Exchange
- FGNX Nasdaq
- NAOV Nasdaq
- Market Cap
- FGNX 5.1M
- NAOV 4.1M
- IPO Year
- FGNX N/A
- NAOV N/A
- Fundamental
- Price
- FGNX $2.56
- NAOV $4.53
- Analyst Decision
- FGNX Strong Buy
- NAOV
- Analyst Count
- FGNX 2
- NAOV 0
- Target Price
- FGNX $10.00
- NAOV N/A
- AVG Volume (30 Days)
- FGNX 1.2M
- NAOV 28.3K
- Earning Date
- FGNX 11-07-2025
- NAOV 11-14-2025
- Dividend Yield
- FGNX N/A
- NAOV N/A
- EPS Growth
- FGNX N/A
- NAOV N/A
- EPS
- FGNX 2.41
- NAOV N/A
- Revenue
- FGNX $24,184,000.00
- NAOV $2,339,000.00
- Revenue This Year
- FGNX $4.72
- NAOV N/A
- Revenue Next Year
- FGNX $73.49
- NAOV N/A
- P/E Ratio
- FGNX $34.85
- NAOV N/A
- Revenue Growth
- FGNX 24.03
- NAOV N/A
- 52 Week Low
- FGNX $2.55
- NAOV $4.40
- 52 Week High
- FGNX $41.25
- NAOV $162.50
- Technical
- Relative Strength Index (RSI)
- FGNX N/A
- NAOV 37.18
- Support Level
- FGNX N/A
- NAOV $4.52
- Resistance Level
- FGNX N/A
- NAOV $5.10
- Average True Range (ATR)
- FGNX 0.00
- NAOV 0.29
- MACD
- FGNX 0.00
- NAOV -0.05
- Stochastic Oscillator
- FGNX 0.00
- NAOV 12.03
About FGNX Fundamental Global Inc. Common Stock
FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.